Hepatic safety of repeated treatment with pyronaridine ‐artesunate versus artemether–lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso

The use of pyronaridine-artesunate (PA) has been associated with scarce transaminitis in patients. This analysis aimed to evaluate the hepatic safety profile of repeated treatment with PA versus artemether –lum...

Source: Malaria Journal - January 29, 2021 Category: Infectious Diseases Authors: Yves Daniel Compaor é, Issaka Zongo, Anyirékun F. Somé, Nouhoun Barry, Frederick Nikiéma, Talato N. Kaboré, Aminata Ouattara, Zachari Kabré, Kadidiatou Wermi, Moussa Zongo, Rakiswende S. Yerbanga, Issaka Sagara, Abdoulaye Djimdé and Jean Bosco Oué Tags: Research Source Type: research